Does AFINITOR Cause Malignant neoplasm progression? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Malignant neoplasm progression have been filed in association with AFINITOR. This represents 9.9% of all adverse event reports for AFINITOR.
70
Reports of Malignant neoplasm progression with AFINITOR
9.9%
of all AFINITOR reports
47
Deaths
25
Hospitalizations
How Dangerous Is Malignant neoplasm progression From AFINITOR?
Of the 70 reports, 47 (67.1%) resulted in death, 25 (35.7%) required hospitalization, and 3 (4.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AFINITOR. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does AFINITOR Cause?
Death (192)
Dyspnoea (58)
Stomatitis (57)
Diarrhoea (47)
Fatigue (44)
Cough (34)
Pyrexia (34)
Rash (29)
Nausea (28)
Drug ineffective (27)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which AFINITOR Alternatives Have Lower Malignant neoplasm progression Risk?
AFINITOR vs AFLIBERCEPT
AFINITOR vs AGALSIDASE ALFA
AFINITOR vs AGALSIDASE BETA
AFINITOR vs AGOMELATINE
AFINITOR vs ALAWAY